Cleveland Diagnostics, Inc., a pioneering, commercial-stage oncology company developing highly accurate diagnostic tests, ...

The Visby Medical test is the first at-home, prescription-free diagnostic for chlamydia, gonorrhea, and trichomoniasis. It provides results in approximately 30 minutes using a self-collected vaginal ...

The first patient was enrolled this month in a Nanostics-sponsored clinical utility study in Calgary to quantify the impact of incorporating ClarityDX Prostate into the standard ...

The Nanostics-sponsored study will recruit 1,074 patients from two Alberta Urology sites, with Dr. Eric Hyndman serving as ...

The Food and Drug Administration (FDA) has cleared the Visby Medical Women’s Sexual Health Test for use at home to test for chlamydia, gonorrhea and trichomoniasis.

This innovative bladder cancer diagnostic kit uses urine samples to achieve 88.8 % sensitivity, promising early detection and reducing the need for cystoscopies.

An article in The Journal of Urology addresses a frustrating feature ... The authors provide a potential diagnostic test for the most common non-cancer diagnosis on prostate biopsy—asymptomatic ...

It is well known that men are reluctant to see a doctor, especially a urologist. As a result, there is a risk that prostate ...

The United Arab Emirates Ministry (UAE) of Health and Prevention has approved Biomerica's Fortel Kidney Disease Test for sale ...

Feb. 13, 2025 — Eating behavior is associated with symptoms of pelvic floor disorders in middle-aged women. For example, higher consumption of highly processed ... Feb. 5, 2025 — New insights ...

A simple urine test could accurately show the recurrence of kidney cancer at an early stage, potentially sparing patients ...